Patents Examined by Catherine M Voorhees
-
Patent number: 12357178Abstract: A mobile electrocardiogram (ECG) device is described, comprising an electrode assembly comprising electrodes that sense heart-related signals when in contact with a body of a user, and produce electrical signals representing the sensed heart-related signals. The mobile ECG device further comprises a light-emitting device to facilitate an optimal placement of the electrode on the body of the user. The mobile ECG device further comprises a housing containing the electrode assembly, the converter assembly, the transmitter, and the light-emitting device. A first electrode of the electrode assembly forms a first side of the housing and comprises an opening through which the light-emitting device provides the UV light.Type: GrantFiled: September 28, 2022Date of Patent: July 15, 2025Assignee: ALIVECOR, INC.Inventors: David E. Albert, Bruce Satchwell
-
Patent number: 12350054Abstract: The present invention provides a stretchable and flexible multi-leads ECG monitoring apparatus having a primary circuitry encased in a thin and flexible polymer patch configured to be worn on a human body. At least four flexible leads are connected to the primary circuitry at a first end and are configured to be connected to ECG electrode patches at a second end. The ECG electrode patches being configured to be attached to a plurality positions on a human body. The wireless transmitter is configured to transmit the ECG monitoring signals to a receiving device for recording or displaying the ECG monitoring signal.Type: GrantFiled: June 12, 2022Date of Patent: July 8, 2025Assignee: City University of Hong KongInventors: Xinge Yu, Yiming Liu, Jingkun Zhou
-
Patent number: 12350493Abstract: A headpiece including a housing, a headpiece magnet carried by the housing, and a headpiece antenna carried by the housing.Type: GrantFiled: October 12, 2022Date of Patent: July 8, 2025Assignee: Advanced Bionics AGInventors: James George Elcoate Smith, Sung Jin Lee, Andreas Benedikt Brehm
-
Patent number: 12343539Abstract: The disclosure relates to an implant comprising a substrate, a housing, wherein the housing is disposed on the substrate, an electronic circuit disposed on the substrate inside the housing, an electronic component disposed on the substrate outside the housing, and a conductor track, wherein the conductor track connects the electronic circuit to the electronic component. The conductor track is embedded into the substrate at least in sections in such a way that at least one section of the conductor track is completely surrounded by the substrate. Furthermore, a method for creating an implant is disclosed.Type: GrantFiled: August 22, 2022Date of Patent: July 1, 2025Assignee: Dyconex AGInventors: Eckardt Bihler, Marc Hauer, Dirk Muessig
-
Patent number: 12337174Abstract: The present disclosure provides a device for state-dependent pudendal nerve stimulation for bladder control in a subject and methods of making and using the same.Type: GrantFiled: January 12, 2024Date of Patent: June 24, 2025Assignee: DUKE UNIVERSITYInventors: Warren M. Grill, James A. Hokanson, Christopher L. Langdale
-
Patent number: 12337168Abstract: According to at least one aspect, a wearable cardiac device is provided. The wearable cardiac device includes a garment worn about a torso of a patient, at least one sensing electrode to monitor cardiac activity of the patient, and a controller including a plurality of separate and distinct modules distributed about and/or integrated into the garment. The plurality of separate and distinct modules includes, for example, an operations module coupled to the at least one sensing electrode and configured to detect at least one cardiac condition of the patient and/or a communications module coupled to the operations module to communicate with an external device. In some examples, the wearable cardiac device may be configured as a treatment device and include an energy storage module coupled to at least one therapy electrode and configured to store energy for at least one therapeutic shock to be applied to the patient.Type: GrantFiled: June 25, 2020Date of Patent: June 24, 2025Assignee: ZOLL Medical CorporationInventors: Thomas E. Kaib, Shane S. Volpe, Gregory R. Frank, Gary A. Freeman, Mark Jerome Owens
-
Patent number: 12336831Abstract: An ECG monitoring device includes a vibration meter sensor unit including at least one vibration meter sensor attached to an instrument at which a person to be observed is positioned, and configured to acquire a vibration signal by detecting a vibration transmitted through the instrument in a non-contact or non-invasive method, a filter unit configured to extract a seismocardiography signal (“SCG signal”) generated by a heart vibration of the person to be observed by receiving the vibration signal and filtering a predetermined frequency band from the received vibration signal, and an ECG waveform acquisition unit including an artificial neural network learned in advance and configured to generate an electrocardiogram signal (“ECG signal”) corresponding to the applied SCG signal according to a learned method.Type: GrantFiled: July 13, 2022Date of Patent: June 24, 2025Assignees: INDUSTRY—ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY, KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGYInventors: Jeong Gil Ko, Shin Ill Kang, In Kyu Park, Jae Yeon Park
-
Patent number: 12336832Abstract: A method includes acquiring intracardiac unipolar signals and intracardiac bipolar signals at a given region of a heart of a patient. The unipolar signals are pruned by eliminating ones of the unipolar signals that correspond in time to respective bipolar signals. One or more unipolar signals are identified among the pruned unipolar signals, that are associated with far-field P-waves. Using the identified P-waves, a window of interest (WOI) is set on electrograms acquired in an atrium of the heart, and, using the electrograms having the set WOI, an electrophysiological (EP) map is generated, of the atrium indicative of atrial tachycardia (AT) tissue locations therein.Type: GrantFiled: March 11, 2022Date of Patent: June 24, 2025Assignee: Biosense Webster (Israel) Ltd.Inventors: Marc Wolff, Elad Nakar, Eliyahu Ravuna, Nir Yanovich, Hadar Reuveny
-
Patent number: 12329964Abstract: Methods are disclosed for electrical stimulation of nerves to treat one or more symptoms in a user. The methods comprise transcutaneously transmitting electrical impulses to the nerve according to a treatment paradigm. The treatment paradigm may include generating and transmitting the electrical impulse as a single dose from about 30 seconds to about 5 minutes. The treatment paradigm may comprise a treatment session of 2 to 4 times within an hour time period and/or as a single dose from 2 to 5 times during a day.Type: GrantFiled: August 1, 2023Date of Patent: June 17, 2025Assignee: ElectroCore, Inc.Inventors: Bruce J. Simon, Joseph P. Errico
-
Patent number: 12318613Abstract: A cochlear implant and analysis system includes a stimulator, an input source, a signal processor, a wireless communication interface, and an external device. The system can receive an acoustic stimulus, generate an input signal representative thereof, and apply a transfer function to the input signal to generate and output a stimulation signal to the stimulator. The signal processor can receive an analysis input indicating a first signal for analysis and generate an analysis signal based on the received analysis input. The first signal can be an input signal from an input source or a result of one or more processing steps. The signal processor can output the analysis signal to the wireless communication interface with the wireless communication interface configured to output a signal representative of the analysis signal to an external device.Type: GrantFiled: November 6, 2023Date of Patent: June 3, 2025Assignee: Envoy Medical CorporationInventor: Paul R. Mazanec
-
Patent number: 12318602Abstract: An extracorporeal cardiac assistance system, comprising a pump being configured to create a fluid flow from a suction line to a pressure line of the system; further comprising a control device configured to control the pump and/or an adjustable flow limiter to provide an adjustable flow rate and/or a pressure, wherein the control device is configured to execute a support mode with a plurality of consecutive support flow rate pulses and/or support pressure pulses interposed on the fluid flow and to execute a weaning mode with a plurality of such pulses, wherein an amount of energy provided to the fluid flow with each pulse is lower in the weaning mode than in the support mode.Type: GrantFiled: December 5, 2019Date of Patent: June 3, 2025Assignee: Xenios AGInventor: Ivo Simundic
-
Patent number: 12318625Abstract: A light applicator (5) for examining and/or treating an organic body includes a minimal-invasive, rigid, semi-flexible or flexible insertion section (11) which extends along a longitudinal direction (L) and at its distal end includes an LED (19). The light applicator (5) includes a first electrical lead (61a) for the supply of electricity to the LED (19). The lead extends in the insertion section (11) in the longitudinal direction (L) and there has a cross-sectional area of at least 70% of the cross-sectional area of the light applicator (5). The light applicator (5) in the insertion section (11) is thermally insulated in the radial direction in a manner such that the radial thermal insulation reduces proximally.Type: GrantFiled: August 13, 2020Date of Patent: June 3, 2025Assignee: RICHARD WOLF GMBHInventors: Bernd Claus Weber, Manfred Wirth
-
Patent number: 12310760Abstract: Systems and methods are provided for monitoring and processing physiological signals (e.g., electrocardiogram signals) to detect and predict for possible dysfunction of an anatomical feature (e.g., cardiac dysfunction) or otherwise predict a likelihood of future cardiac dysfunction of the individual. For example, a system comprises a plurality of sensors, a physiological signal processing system, and a feature analysis system. The sensors are configured to monitor physiological signals from an individual that has undergone a medical procedure on an anatomical feature. The physiological signal processing system is configured to analyze the physiological signals and extract features from the physiological signals which are indicative of a function of the anatomical feature.Type: GrantFiled: May 7, 2020Date of Patent: May 27, 2025Assignee: LifeLens Technologies, LLCInventors: Landy Toth, Robert S. Schwartz, Jonathan G. Schwartz
-
Patent number: 12295734Abstract: Provided is a wireless electrocardiogram monitoring device comprising: a patch part including a plurality of electrodes; and a module part detachably coupled to the patch part and capable of wireless communication with an external device, wherein the patch part comprises: a downward patch part formed at the bottom surface to be attached to the human body while some of the plurality of electrodes are exposed from the bottom surface; and an upward patch part disposed at the top surface opposite to the bottom surface while the others of the plurality of electrodes are exposed from the top surface.Type: GrantFiled: December 18, 2019Date of Patent: May 13, 2025Assignee: HUMANOO LAB, INC.Inventors: Seong Je Cho, Seung Phil Jung
-
Patent number: 12296164Abstract: Embodiments of the present invention provide a system (100) for providing targeted cue delivery to regulate a gait of a user comprising a first cue delivery device (131) configured to provide somatosensory stimulation to a first leg of the user, a second cue delivery device (132) configured to provide somatosensory stimulation to a second leg of the user, one or more inertial sensors (121, 122) configured to output movement data indicative of the gait of the user, and a controller (110) configured to receive the movement data from the one or more inertial sensors (121, 122), determine a cue pattern for each of the first and second cue delivery devices (131, 132) independence on the movement data, and output a respective control signal (135, 136) to control each of the first and second cue delivery devices (135, 136) to provide stimulation according to the cue pattern.Type: GrantFiled: October 22, 2020Date of Patent: May 13, 2025Assignee: OXFORD UNIVERSITY INNOVATION LIMITEDInventors: James Cantley, Dongli Li
-
Patent number: 12290693Abstract: Various embodiments of an electronics module and an implantable medical device that includes such module are disclosed. The module includes a feedthrough header assembly having a conductive header that includes a conductive inner surface, an outer surface, and a contact disposed on the inner surface and electrically connected to the header; and a feedthrough pin disposed within a via that extends through the header. The module further includes an electronic layer having a substrate and an electronic component disposed on or within the substrate. The electronic component is electrically connected to the contact of the conductive header such that the electronic component is electrically connected to the header. A major surface of the substrate of the electronic layer faces the conductive inner surface of the header without any intervening nonconductive layers disposed between the major surface of the substrate and the conductive inner surface of the header.Type: GrantFiled: January 28, 2022Date of Patent: May 6, 2025Assignee: Medtronic, Inc.Inventors: Mark E. Henschel, Andrew J. Ries, Songhua Shi, Jemmy Sutanto, Lea Ann Nygren
-
Patent number: 12285276Abstract: Provided are a system and a computer program for managing and predicting thyrotoxicosis using a wearable device. The system for predicting thyrotoxicosis is a system for predicting thyrotoxicosis using a resting heart rate, the system including a wearable device for measuring the heart rate of a patient at regular intervals, and a bio-signal computing device for receiving heart rate information from the wearable device, the bio-signal computing device outputting a warning alarm when a resting heart rate is greater than a reference heart rate when the patient is in a normal state.Type: GrantFiled: January 16, 2024Date of Patent: April 29, 2025Assignee: THYROSCOPE INC.Inventor: Jae Hoon Moon
-
Patent number: 12285602Abstract: A method for treating pain or discomfort in a patient is disclosed. The method comprises stimulating a cranial nerve with an electrical signal. The pain or discomfort may be a withdrawal symptom. The cranial nerve may be in an auricular area of the patient. The cranial nerve may be cranial nerve V, cranial nerve VII, cranial nerve IX, cranial nerve X, or branches of greater and lesser occipital nerves thereof and their associated neurovascular bundles. The withdrawal symptom may result from cessation of an opioid. The method may further comprise administering a secondary drug treats one or more of the withdrawal symptoms and addiction. The secondary drug may be administered about one day to about one week after initiating the stimulating step.Type: GrantFiled: October 9, 2023Date of Patent: April 29, 2025Assignee: NEURAXIS, INC.Inventors: Christopher R. Brown, Gary M. Peterson
-
Patent number: 12280252Abstract: According to an aspect of the present disclosure, an electrical muscle stimulation system including a control device configured to generate a wireless control signal for controlling an operation of the electrical muscle stimulation suit, may include a buoy module configured to float on a surface of the surface, the electrical muscle stimulation suit may include at least one electrode pad attached to a region corresponding to each muscle part of the user, the buoy module may include a first communication module provided at a position of the buoy module, for transmitting the wireless control signal through air, without passing through water, and wherein the wireless control signal may be transmitted to the electrode pad through wired connection to the electrode pad.Type: GrantFiled: December 13, 2021Date of Patent: April 22, 2025Assignee: COREMOVEMENT CO., LTD.Inventors: Myeongcheol Kim, Seongwoo Je, Junsul Park
-
Patent number: 12280253Abstract: An extravascular or intravascular neural interface is disclosed comprising three C-ring portions, with at least two including an electrode, an electrode pair or an electrode array. The portions are formed of a flexible material that is configured to enable the portions to self-size to fit around or against a surface of a target vessel when the neural interface is released at a position along the target vessel. A spinal portion configured to house electrical conductors for the electrodes is connected to one or more portions. The portions may be spaced sufficient apart to permit radial expansion and contraction of a target vessel around or within which the neural interface is placed, to reduce never compression, open trench low-pressure unrestricted blood-flow, and to enhance fluid exchange with the target vessel. The portions may be arranged in a low helix angle forming at least two full turns.Type: GrantFiled: February 5, 2021Date of Patent: April 22, 2025Assignee: GALVANI BIOELECTRONICS LIMITEDInventors: Faisal Zaidi, Sabastien Ouchouche, Paul Matteucci